Arteriovenous malformations (patient information): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Adding CME Category::Cardiology |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 17: | Line 17: | ||
==Treatment options== | ==Treatment options== | ||
===Medications to avoid=== | |||
{{MedCondContrPI | |||
|MedCond = intracranial ateriovenous malformation|Abciximab|Alteplase|Reteplase|Tenecteplase|Urokinase}} | |||
==Where to find medical care for Arteriovenous malformations?== | ==Where to find medical care for Arteriovenous malformations?== | ||
Line 30: | Line 35: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Congenital disorders]] | [[Category:Congenital disorders]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Latest revision as of 00:09, 15 March 2016
(Arteriovenous malformations) |
(Condition) On the Web |
---|
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
What are the symptoms of Arteriovenous malformations?
What causes Arteriovenous malformations?
Who is at highest risk?
Diagnosis
When to seek urgent medical care?
Treatment options
Medications to avoid
Patients diagnosed with intracranial ateriovenous malformation should avoid using the following medications:
- Abciximab
- Alteplase
- Reteplase
- Tenecteplase
- Urokinase
If you have been diagnosed with intracranial ateriovenous malformation, consult your physician before starting or stopping any of these medications.